Presenilin-1 mutations in Alzheimer's disease

被引:0
|
作者
C. Russo
G. Schettini
T. C. Saido
C. Hulette
C. Lippa
L. Lannfelt
B. Ghetti
P. Gambetti
M. Tabaton
J. K. Teller
机构
[1] Institute of Pathology,Division of Neuropathology
[2] Case Western Reserve University,Neuroscience Department
[3] National Institute for Cancer Research Advanced Biotechnology Center,Department of Neurology
[4] Section of Pharmacology University of Genova,Department of Pathology
[5] Laboratory for Proteolytic Neuroscience,Department of Physiology, Brody School of Medicine
[6] RIKEN Brain Science Institute,undefined
[7] Kathleen Price Bryan Brain Bank and Neuropathology Core,undefined
[8] Duke University Medical Center,undefined
[9] MCP Hahnemann University,undefined
[10] Karolinska Institute,undefined
[11] Geriatric Laboratory,undefined
[12] Huddinge Hospital,undefined
[13] Indiana University Medical Center,undefined
[14] Institute of Neurology,undefined
[15] East Carolina University,undefined
来源
Nature | 2000年 / 405卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Mutations in the gene encoding the protein presenilin-1 are the most common cause of familial Alzheimer's disease1 and they often produce a different disease course from sporadic Alzheimer's and another familial form associated with mutations in the gene encoding β-amyloid precursor protein2. Here we show that a peculiar form of β-amyloid that is devoid of the first ten amino acids accumulates in the brains of patients carrying presenilin-1 mutations, and is more abundant than in subjects affected by the other types of Alzheimer's.
引用
收藏
页码:531 / 532
页数:1
相关论文
共 50 条
  • [1] Presenilin-1 mutations and Alzheimer's disease
    Kelleher, Raymond J., III
    Shen, Jie
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (04) : 629 - 631
  • [2] Presenilin-1 gene mutations in Alzheimer's disease
    Mann, DMA
    [J]. BRAIN PATHOLOGY, 2000, 10 (04) : 713 - 713
  • [3] Neurobiology - Presenilin-1 mutations in Alzheimer's disease
    Russo, C
    Schettini, G
    Saido, TC
    Hulette, C
    Lippall, C
    Lannfelt, L
    Ghetti, B
    Gambetti, P
    Tabaton, M
    Teller, JK
    [J]. NATURE, 2000, 405 (6786) : 531 - 532
  • [4] Monogenic determinants of familial Alzheimer's disease: Presenilin-1 mutations
    Kovacs, DM
    Tanzi, RE
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 1998, 54 (09) : 902 - 909
  • [5] Monogenic determinants of familial Alzheimer's disease: presenilin-1 mutations
    D. M. Kovacs
    R. E. Tanzi
    [J]. Cellular and Molecular Life Sciences CMLS, 1998, 54 : 902 - 909
  • [6] Presenilin-1 polymorphism and Alzheimer's disease
    Higuchi, S
    Muramatsu, T
    Matsushita, S
    Arai, H
    Sasaki, H
    [J]. LANCET, 1996, 347 (9009): : 1186 - 1186
  • [7] Presenilin-1 polymorphism and Alzheimer's disease
    Owen, MJ
    Kehoe, P
    Williams, J
    [J]. LANCET, 1996, 348 (9024): : 414 - 414
  • [8] Presenilin-1 polymorphism and Alzheimer's disease
    Scott, WK
    Roses, AD
    Haines, JL
    PericakVance, MA
    [J]. LANCET, 1996, 347 (9014): : 1560 - 1560
  • [9] Familial Alzheimer's disease mutations enhance apoptotic effects of presenilin-1
    Kovacs, DM
    Mancini, R
    Na, S
    Kim, TW
    Tanzi, RE
    [J]. ALZHEIMER'S DISEASE AND RELATED DISORDERS: ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 1999, : 607 - 612
  • [10] Plaque pathology in presenilin-1 Alzheimer's disease
    Shepherd, C
    Gregory, G
    McCann, H
    Halliday, G
    Kwok, J
    Schofield, P
    Kril, J
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S220 - S220